###begin article-title 0
Are Viruses Inhibited by APOBEC3 Molecules from Their Host Species?
###end article-title 0
###begin p 1
###xml 416 419 416 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Goff1">[1]</xref>
###xml 431 434 431 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Loo1">[2]</xref>
###xml 450 453 450 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Neil1">[3]</xref>
###xml 454 457 454 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-VanDamme1">[4]</xref>
###xml 476 479 476 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Sheehy1">[5]</xref>
###xml 936 939 936 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Okeoma1">[6]</xref>
###xml 940 943 940 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Takeda1">[8]</xref>
###xml 764 770 <span type="species:ncbi:10090">murine</span>
###xml 870 876 <span type="species:ncbi:10090">murine</span>
Organisms adapt to infectious agents by developing protective responses, and conversely, infectious agents develop adaptive countermeasures to these responses. Host defenses against infectious agents include adaptive and innate immune responses (e.g., natural killer cells, Toll-like receptors, and interferons). Recently, additional host defense systems against viruses have been identified. These include the TRIM [1], RIGI/MDA5 [2], Bst2/tetherin [3],[4], and APOBEC3 (A3) [5] proteins. Many of these anti-viral defense mechanisms were identified through the discovery of viral gene products that counteract their action, and thus it has been proposed that only viruses resistant to host-encoded restriction factors persist. However, recent in vivo work in the murine system has indicated that endogenous A3 proteins play important roles in limiting pathogenicity by murine viruses even though they only partially restrict infection [6]-[8]. Here I argue that these recent studies emphasize the critical importance of studying natural pathogenic viruses and host restriction factors in vivo.
###end p 1
###begin p 2
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Cullen1">[9]</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Vartanian1">[10]</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Conticello1">[11]</xref>
###xml 415 417 415 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3</italic>
###xml 419 422 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hA3</italic>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Munk1">[12]</xref>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Bogerd1">[13]</xref>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-LaRue1">[14]</xref>
###xml 561 563 561 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3</italic>
###xml 565 568 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mA3</italic>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Conticello2">[15]</xref>
###xml 585 587 585 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3</italic>
###xml 707 710 707 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Takeda1">[8]</xref>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Munk1">[12]</xref>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Zhang1">[16]</xref>
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-OhAinle2">[19]</xref>
###xml 856 865 856 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000347-g001">Figure 1A</xref>
###xml 887 891 887 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Munk1">[12]</xref>
###xml 910 914 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-LaRue1">[14]</xref>
###xml 111 116 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 152 169 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 171 174 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 180 185 <span type="species:ncbi:9606">human</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 463 468 <span type="species:ncbi:9796">horse</span>
###xml 539 544 <span type="species:ncbi:10090">mouse</span>
###xml 849 854 <span type="species:ncbi:10090">mouse</span>
A3 proteins belong to a family of genes that encode DNA- and RNA-editing enzymes and confer innate immunity to HIV-1 and perhaps other viruses, such as hepatitis B virus (HBV) and human papilloma virus (HPV) [9],[10]. The A3 genes arose through gene duplication of a single-copy primordial gene, are found in a tandem array, and have expanded or contracted in different species [11]; the human genome encodes seven A3 (hA3) genes, the feline four genes [12], the horse six genes [13], artiodactyls species two to three genes [14], and the mouse genome a single A3 (mA3) gene [15]. The A3 genes in general show a high degree of polymorphic variation, suggesting that they are under strong selective pressure [8], [12], [16]-[19]. Additionally, alternatively spliced RNAs with the potential for generating different A3 proteins have been found in the mouse (Figure 1A; see below), felines [12], and artiodactyls [14].
###end p 2
###begin title 3
Polymorphisms in APOBEC 3 Genes.
###end title 3
###begin p 4
###xml 471 474 471 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Santiago1">[7]</xref>
###xml 475 478 475 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Takeda1">[8]</xref>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Miyazawa1">[65]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Okeoma2">[66]</xref>
###xml 504 506 504 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3</italic>
###xml 650 653 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3G</italic>
###xml 745 749 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-An1">[69]</xref>
###xml 870 873 870 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3A</italic>
###xml 874 876 874 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3B</italic>
###xml 882 886 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Kidd1">[71]</xref>
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
###xml 524 529 <span type="species:ncbi:9606">human</span>
###xml 612 618 <span type="species:ncbi:9606">humans</span>
###xml 722 727 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Different splice variants and polymorphic exons found in different inbred mouse strains. Blue boxes denote exons found in inbred strains such as BALB/c and 129; red boxes denote exons with polymorphic amino acid differences in C57BL-derived strains. The table denotes the relative expression levels of the different splice variants expressed in the different strains, as well as the susceptibility (S) or resistance (R) to F-MLV infection. Data taken from references [7],[8],[65],[66]. (B) Different A3 alleles found in human populations. At least seven SNP polymorphisms have been found in the A3G genes in humans, although only one polymorphic A3G allele, H186R, has been associated with increased susceptibility to HIV-1-mediated disease [69]. Also shown is the presumed recombination event leading to the deletion of part of A3B in some individuals and a fused hA3A/3B gene [71].
###end p 4
###begin p 5
###xml 131 134 131 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Sheehy1">[5]</xref>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 216 219 216 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Newman1">[20]</xref>
###xml 707 710 707 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Mehle1">[21]</xref>
###xml 874 878 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Marin1">[24]</xref>
###xml 1107 1111 1107 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Delebecque1">[25]</xref>
###xml 1112 1116 1112 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Russell1">[27]</xref>
###xml 1321 1325 1321 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Bogerd2">[28]</xref>
###xml 1326 1330 1326 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Schumacher1">[34]</xref>
###xml 1541 1545 1541 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Jern1">[35]</xref>
###xml 1546 1550 1546 1550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Armitage1">[37]</xref>
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 185 190 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 230 235 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 579 584 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 712 717 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1215 1220 <span type="species:ncbi:9606">human</span>
###xml 1225 1230 <span type="species:ncbi:10090">mouse</span>
###xml 1273 1278 <span type="species:ncbi:9606">human</span>
###xml 1463 1484 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 1486 1489 <span type="species:ncbi:11786">MLV</span>
hA3G, the first identified family member, was discovered because of its interaction with the HIV-1 virion infectivity factor (Vif) [5]. hA3G and subsequently hA3F were shown to inhibit HIV-1 lacking the vif gene. In vif-deficient HIV-1 producer cells, both hA3G and hA3F are packaged into progeny virions via interaction with the nucleocapsid (NC) protein and viral RNA. Once packaged, hA3 proteins inhibit infection in target cells by deaminating deoxycytidine residues on the DNA minus strand following reverse transcription, inducing G to A hypermutation in newly synthesized HIV-1 DNA. A3 proteins also inhibit replication by cytidine deaminase (CDA)-independent mechanisms [20]. In cells infected with vif+ HIV-1, Vif binds hA3G and hA3F and targets these proteins for ubiquitinylation and degradation in the proteosome, thereby overcoming the anti-viral activity [21]-[24]. Simian immunodeficiency viruses (SIVs) also encode Vif proteins, while foamy viruses (FVs) encode a protein (Bet) that interacts with A3G and prevents its packaging via a mechanism that is apparently different from that of Vif [25]-[27]. There are also a large number of studies demonstrating that A3 proteins inhibit transposition of human and mouse retroelements, such as LINE-1, Alu, MusD, human endogenous retroviruses (HERVs), and IAPs [28]-[34]. Although no study has directly examined the effect of A3 proteins on endogenous copies of these elements, both HERV and endogenous murine leukemia virus (MLV) sequences bear signatures of cytidine deamination [35]-[37].
###end p 5
###begin p 6
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Navarro1">[38]</xref>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Zhang2">[46]</xref>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Sasada1">[47]</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Rulli1">[50]</xref>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Abudu1">[45]</xref>
###xml 908 912 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Bogerd1">[13]</xref>
###xml 289 294 <span type="species:ncbi:9606">human</span>
###xml 355 359 <span type="species:ncbi:11855?1.0">MPMV</span>
###xml 366 369 <span type="species:ncbi:11786">MLV</span>
###xml 397 402 <span type="species:ncbi:9606">human</span>
###xml 415 420 <span type="species:ncbi:10090">mouse</span>
###xml 610 613 <span type="species:ncbi:11786">MLV</span>
###xml 658 661 <span type="species:ncbi:11786">MLV</span>
###xml 757 787 <span type="species:ncbi:11665">equine infectious anemia virus</span>
###xml 817 822 <span type="species:ncbi:9796">horse</span>
###xml 890 895 <span type="species:ncbi:9606">human</span>
Several studies have examined packaging of A3 proteins from different species into retroviruses endemic to the species using transfected tissue culture cells and have suggested that these viruses are resistant to the A3 proteins of their natural hosts. For example, it has been shown that human T cell leukemia virus I (HTLVI), Mason Pfizer monkey virus (MPMV), and MLV do not efficiently package human, monkey, or mouse A3 proteins, respectively, because of weak interactions between the NC proteins and the host A3 [38]-[46], although other studies have shown some packaging of host A3 proteins by HTLVI and MLV as well as viral restriction [47]-[50]. The MLV protease may also degrade mA3, thereby preventing its anti-viral function [45]. More recently, equine infectious anemia virus was shown to package several horse A3 proteins but these did not diminish infection as effectively as human A3 proteins [13].
###end p 6
###begin p 7
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Yu2">[51]</xref>
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Okeoma1">[6]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Delebecque1">[25]</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Doehle2">[42]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Bishop1">[44]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Mariani1">[48]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Langlois1">[52]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Mangeat1">[54]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Doehle2">[42]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Kobayashi1">[43]</xref>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Mangeat1">[54]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Aguiar1">[55]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Rulli1">[50]</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Schrofelbauer1">[56]</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Bogerd4">[59]</xref>
###xml 908 912 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Mariani1">[48]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Doehle1">[40]</xref>
###xml 940 944 940 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Russell1">[27]</xref>
###xml 1099 1102 1099 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Cullen1">[9]</xref>
###xml 196 201 <span type="species:ncbi:9606">Human</span>
###xml 223 226 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 251 269 <span type="species:ncbi:11886">Rous sarcoma virus</span>
###xml 282 285 <span type="species:ncbi:11786">MLV</span>
###xml 291 316 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
###xml 318 322 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 379 384 <span type="species:ncbi:9606">human</span>
###xml 440 443 <span type="species:ncbi:11786">MLV</span>
###xml 514 519 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 651 657 <span type="species:ncbi:9606">humans</span>
###xml 659 670 <span type="species:ncbi:9598">chimpanzees</span>
###xml 675 690 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 766 772 <span type="species:ncbi:9606">humans</span>
###xml 774 795 <span type="species:ncbi:9534">African green monkeys</span>
###xml 847 852 <span type="species:ncbi:10090">mouse</span>
###xml 892 897 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 914 918 <span type="species:ncbi:11855?1.0">MPMV</span>
In contrast to studies demonstrating that endogenous A3 proteins do not restrict retroviruses that infect the same species, there are many examples of cross-species restriction in cultured cells. Human A3B and A3C restrict SIV [51] and hA3G restricts Rous sarcoma virus, feline FV, MLV, and mouse mammary tumor virus (MMTV) [6], [25], [42]-[44], [48], [52]-[54]. Indeed, several human A3 proteins including hA3G have been shown to restrict MLV via deamination [42],[43],[54],[55], although to a lesser extent than HIV-1 [50]. There is also species-specific degradation of hA3G proteins by different Vifs. For example, Vifs encoded by SIVs that infect humans (chimpanzees and sooty mangabeys) can cause the degradation of hA3G, while Vifs from SIVs that don't infect humans (African green monkeys) don't interact with hA3G [56]-[59]. Additionally, mouse A3, which does not bind Vif, restricts HIV-1 infection [48], MPMV [40], and primate FV [27] via a CDA-dependent mechanism. Thus, it has been proposed that one role for A3 proteins is to prevent zoonoses rather than to restrict natural infections [9].
###end p 7
###begin p 8
###xml 371 373 371 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3</italic>
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
###xml 182 186 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 191 194 <span type="species:ncbi:11786">MLV</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
However, the studies showing that A3 proteins do not restrict viruses that infect the same species need to be re-evaluated in light of several recent studies with two mouse viruses, MMTV and MLV. These in vivo studies examined the role of A3 in the resistance and susceptibility to infection in different inbred strains of mice and in mice with targeted deletion of the mA3 gene and clearly demonstrate that the host A3 protein plays a role in virus infection and, more importantly, in virus-mediated pathogenesis.
###end p 8
###begin p 9
###xml 139 142 139 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Okeoma1">[6]</xref>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Ross1">[60]</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 134 138 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 144 148 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 757 761 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
In the first of these studies, our lab tested whether knockout mice that lack a functional A3 gene were susceptible to infection with MMTV [6]. MMTV is a betaretrovirus that is normally acquired through milk by suckling neonates and first infects cells in the lymphoid compartment followed by transmission to the mammary epithelial cells [60]. We infected mA3+/+ and mA3-/- mice and showed that mA3-/- mice had higher levels of initial infection compared to their wild-type littermates and moreover, that virus spread was more rapid and extensive. We have also found that MMTV-infected mA3-/- mice develop mammary tumors more rapidly (C. Okeoma and S. Ross, unpublished data). These findings demonstrate that mA3 provides partial protection to mice against MMTV infection and represent the first demonstration to our knowledge that A3 proteins function during in vivo retroviral infection.
###end p 9
###begin p 10
###xml 130 133 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Santiago1">[7]</xref>
###xml 134 137 134 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Takeda1">[8]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Steeves1">[61]</xref>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rfv</italic>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Chesebro1">[62]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Hasenkrug1">[63]</xref>
###xml 594 597 594 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rfv</italic>
###xml 659 666 659 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3</italic>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Kanari1">[64]</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Miyazawa1">[65]</xref>
###xml 730 733 730 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rfv</italic>
###xml 740 742 740 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3</italic>
###xml 815 818 815 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Santiago1">[7]</xref>
###xml 819 822 819 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Takeda1">[8]</xref>
###xml 69 72 <span type="species:ncbi:11786">MLV</span>
###xml 76 79 <span type="species:ncbi:11786">MLV</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 316 319 <span type="species:ncbi:11786">MLV</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 855 859 <span type="species:ncbi:10090">mice</span>
###xml 891 894 <span type="species:ncbi:11786">MLV</span>
###xml 912 916 <span type="species:ncbi:10090">mice</span>
###xml 929 932 <span type="species:ncbi:11786">MLV</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
###xml 1179 1182 <span type="species:ncbi:11786">MLV</span>
###xml 1233 1237 <span type="species:ncbi:10090">mice</span>
Two groups more recently demonstrated that mA3 also restricts Friend MLV (F-MLV) infection and virus-induced erythroproliferation [7],[8]. In the 1970s, genetic crosses between various strains of inbred mice were carried out as a means of identifying genetic loci that would confer susceptibility or resistance to F-MLV [61]. The recovery from Friend virus 3 (Rfv3) locus was subsequently found to affect the ability of resistant mice, such as C57BL/6, to recover from virus infection, at least in part through the production of a high-level antibody response [62],[63]. Mapping studies placed Rfv3 to a 0.83 centimorgan region of chromosome 15, close to the APOBEC3 locus [64],[65]. The Greene and Miyazawa groups tested whether Rfv3 and mA3 were one and the same, and their data suggest that this may be the case [7],[8]. Both groups showed that mA3-/- mice were more highly infected by F-MLV than were mA3+/+ mice, and when F-MLV-susceptible (BALB/c) mice were crossed with mA3-/- mice and infected with virus, the F1 progeny had high virus titers, did not develop a strong neutralizing antibody response, and showed increased erythroid cell proliferation characteristic of F-MLV-mediated disease. Conversely, mA3-/- X C57BL/6 F1 mice looked like their resistant parent, with low viremia and high antibody production.
###end p 10
###begin p 11
###xml 308 311 308 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Santiago1">[7]</xref>
###xml 312 315 312 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Takeda1">[8]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Abudu1">[45]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Miyazawa1">[65]</xref>
###xml 392 401 388 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000347-g001">Figure 1A</xref>
###xml 403 406 399 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Santiago1">[7]</xref>
###xml 407 410 403 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Takeda1">[8]</xref>
###xml 411 415 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Okeoma2">[66]</xref>
###xml 1043 1047 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Okeoma2">[66]</xref>
###xml 1116 1119 1112 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Santiago1">[7]</xref>
###xml 1120 1124 1116 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Miyazawa1">[65]</xref>
###xml 1125 1129 1121 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Okeoma2">[66]</xref>
###xml 1248 1252 1244 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Okeoma2">[66]</xref>
###xml 158 161 <span type="species:ncbi:11786">MLV</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 1022 1026 <span type="species:ncbi:10090">mice</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
###xml 1183 1187 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1243 1247 <span type="species:ncbi:10090">mice</span>
###xml 1379 1383 <span type="species:ncbi:10090">mice</span>
###xml 1460 1463 <span type="species:ncbi:11786">MLV</span>
###xml 1468 1472 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
The two groups differed in their conclusions regarding the mechanism of A3-mediated resistance. There are a number of differences between the A3 alleles in F-MLV-resistant and -susceptible mice, leading to differences in mRNA expression levels, alternative splicing of the mRNA, and amino acid polymorphisms [7],[8],[45],[65]. C57BL/6 mice predominantly express a Deltaexon 5 variant of mA3 (Figure 1A) [7],[8],[66]. Using a transfection/infection assay with hybrid A3 molecules, Takeda and colleagues mapped the ability of the C57BL6-derived allele to restrict infection to polymorphic amino acids in the N-terminal 192 amino acid region and not to the absence of exon 5. In contrast, Santiago and colleagues suggested that a lack of exon 2 in the mA3 made in BALB/c (or A.BY) susceptible mice contributes to the inability of mA3 from these backgrounds to inhibit infection, although this transcript was not detected in the studies by Takeda et al. and our lab has more recently found that the major transcript in BALB/c mice contains exon 2 [66]. C57BL/6 mice also express higher levels of A3 RNA than BALB/c mice [7],[65],[66]. We also found that the C57BL/6 mA3 allele restricts MMTV infection more effectively than that encoded in BALB/c mice [66]. Which of these differences contribute to resistance to virus infection in vivo awaits the creation of transgenic or knock-in mice with the different alleles to directly test their efficacy in restricting F-MLV and MMTV.
###end p 11
###begin p 12
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Kobayashi1">[43]</xref>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Bishop1">[44]</xref>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Browne1">[49]</xref>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Rulli1">[50]</xref>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Schafer1">[67]</xref>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Low1">[68]</xref>
###xml 680 684 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rfv3</italic>
###xml 688 691 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mA3</italic>
###xml 244 247 <span type="species:ncbi:11786">MLV</span>
###xml 462 465 <span type="species:ncbi:11786">MLV</span>
###xml 469 472 <span type="species:ncbi:11786">MLV</span>
###xml 488 491 <span type="species:ncbi:11786">MLV</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 615 618 <span type="species:ncbi:11786">MLV</span>
###xml 637 640 <span type="species:ncbi:11786">MLV</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
###xml 769 775 <span type="species:ncbi:10090">murine</span>
###xml 790 794 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 799 802 <span type="species:ncbi:11786">MLV</span>
Importantly, these studies demonstrate that the tissue culture experiments that examine the role of host restriction factors can underestimate the role that these restriction factors play in vivo. The numerous studies regarding mA3's effect on MLV infection in cultured cells are conflicting, providing evidence for and against a role in restriction [43],[44],[49],[50],[67]. Although the tissue culture studies predominantly examined the role of mA3 on Moloney MLV (M-MLV) rather than F-MLV, a recent study also shows that mA3-/- mice are more susceptible than mA3+/+ mice to infection and lymphoma induction by M-MLV [68]. While the F-MLV studies do not definitively prove that Rfv3 is mA3, the fact that mA3-/- mice are more susceptible to infection by at least two murine retroviruses, MMTV and MLV, and that the loss of this gene in vivo leads to increased pathogenesis by these viruses, provides strong support that this host-encoded restriction factor does function against a natural pathogen.
###end p 12
###begin p 13
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Kanari1">[64]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Miyazawa1">[65]</xref>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-An1">[69]</xref>
###xml 639 641 639 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3</italic>
###xml 662 665 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3G</italic>
###xml 670 673 670 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3H</italic>
###xml 757 761 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-OhAinle1">[18]</xref>
###xml 762 766 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-OhAinle2">[19]</xref>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-An2">[70]</xref>
###xml 810 813 810 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3B</italic>
###xml 843 846 843 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3A</italic>
###xml 847 849 847 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3B</italic>
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Kidd1">[71]</xref>
###xml 861 870 861 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000347-g001">Figure 1B</xref>
###xml 1068 1072 1068 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000347-Harari1">[72]</xref>
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 107 112 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 207 212 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 335 338 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 414 419 <span type="species:ncbi:9606">human</span>
###xml 633 638 <span type="species:ncbi:9606">human</span>
###xml 955 959 <span type="species:ncbi:10090">mice</span>
###xml 1061 1067 <span type="species:ncbi:9606">humans</span>
###xml 1240 1245 <span type="species:ncbi:9606">human</span>
What does this mean for HIV-1 and other human pathogens and the role that hA3 proteins play in restricting HIV-1 infection? There is increasing genetic evidence that A3 proteins protect against infection by HIV-1 and other viruses. Indeed, one of the alleles that has been linked to individuals who have received multiple exposures to HIV but remained sero-negative maps to chromosome 22q12-13, which contains the human A3 family member genes [64],[65]. One A3G polymorphism, H16R, is associated with AIDS progression and declining CD4 T cells, although the in vitro anti-viral activity of the two alleles was the same [69]. Several human A3 genes, particularly A3G and A3H, are highly polymorphic, suggesting positive selection by viruses or retroelements [18],[19],[70], and there is a known deletion in the A3B locus that leads to a fused hA3A/3B gene [71] (Figure 1B). Although alternative splicing has been shown to generate different A3 proteins in mice, artiodactyls, and felines, thus far only APOBEC3H has been shown to undergo alternative splicing in humans [72]. This represents another potential means of generating A3 proteins that more effectively restrict infection and needs to be more thoroughly examined for the different human genes.
###end p 13
###begin p 14
###xml 558 560 558 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3</italic>
###xml 689 696 689 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 308 313 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 356 362 <span type="species:ncbi:9606">humans</span>
###xml 600 605 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 614 617 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The mouse studies underscore the importance of using in vivo models to understand host restriction factors and their importance in limiting viral pathogenesis. Unfortunately, the lack of a good animal model means we can at present only infer that A3G or other A3 molecules are retained in the genome as anti-HIV-1 (or other viruses) restriction factors in humans and other species. In the absence of being able to test species-specific A3 molecules in vivo against species-endemic viruses, it is critical to look for genetic associations between polymorphic A3 alleles and resistance to infection to HIV-1, HTLVI, HBV, HPV, and other viruses whose infection may be affected by A3 proteins in vivo.
###end p 14
###begin p 15
I regret that I am unable to cite all of the relevant papers because of space limitations. I thank the members of my laboratory for helpful discussions.
###end p 15
###begin title 16
References
###end title 16
###begin article-title 17
Retrovirus restriction factors.
###end article-title 17
###begin article-title 18
Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.
###end article-title 18
###begin article-title 19
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
###end article-title 19
###begin article-title 20
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.
###end article-title 20
###begin article-title 21
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
###end article-title 21
###begin article-title 22
###xml 17 42 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
APOBEC3 inhibits mouse mammary tumor virus replication in vivo.
###end article-title 22
###begin article-title 23
Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.
###end article-title 23
###begin article-title 24
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse APOBEC3 restricts Friend leukemia virus infection and pathogenesis in vivo.
###end article-title 24
###begin article-title 25
Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors.
###end article-title 25
###begin article-title 26
###xml 24 44 <span type="species:ncbi:10566">human papillomavirus</span>
Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions.
###end article-title 26
###begin article-title 27
The AID/APOBEC family of nucleic acid mutators.
###end article-title 27
###begin article-title 28
Functions, structure, and read-through alternative splicing of feline APOBEC3 genes.
###end article-title 28
###begin article-title 29
###xml 0 30 <span type="species:ncbi:11665">Equine infectious anemia virus</span>
###xml 71 77 <span type="species:ncbi:9796">equine</span>
Equine infectious anemia virus resists the anti-retroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.
###end article-title 29
###begin article-title 30
The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals.
###end article-title 30
###begin article-title 31
Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
###end article-title 31
###begin article-title 32
Rapid evolution of primate antiviral enzyme APOBEC3G.
###end article-title 32
###begin article-title 33
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.
###end article-title 33
###begin article-title 34
Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.
###end article-title 34
###begin article-title 35
###xml 63 68 <span type="species:ncbi:9606">human</span>
Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.
###end article-title 35
###begin article-title 36
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.
###end article-title 36
###begin article-title 37
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
###end article-title 37
###begin article-title 38
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
###end article-title 38
###begin article-title 39
###xml 12 17 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif.
###end article-title 39
###begin article-title 40
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
###end article-title 40
###begin article-title 41
Restriction of foamy viruses by APOBEC cytidine deaminases.
###end article-title 41
###begin article-title 42
###xml 59 70 <span type="species:ncbi:11963">foamy virus</span>
The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein.
###end article-title 42
###begin article-title 43
###xml 0 11 <span type="species:ncbi:11963">Foamy virus</span>
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.
###end article-title 43
###begin article-title 44
###xml 79 84 <span type="species:ncbi:9606">human</span>
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells.
###end article-title 44
###begin article-title 45
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.
###end article-title 45
###begin article-title 46
###xml 34 56 <span type="species:ncbi:272636">adeno-associated virus</span>
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.
###end article-title 46
###begin article-title 47
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
###end article-title 47
###begin article-title 48
Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses.
###end article-title 48
###begin article-title 49
###xml 137 143 <span type="species:ncbi:10090">murine</span>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 159 165 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
Restriction by APOBEC3 proteins of endogenous retroviruses with an extracellular life cycle: ex vivo effects and in vivo "traces" on the murine IAPE and human HERV-K elements.
###end article-title 49
###begin article-title 50
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD and HIV-1 restriction.
###end article-title 50
###begin article-title 51
###xml 54 77 <span type="species:ncbi:11786">murine leukemia viruses</span>
Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses.
###end article-title 51
###begin article-title 52
###xml 28 33 <span type="species:ncbi:9606">human</span>
Hypermutation of an ancient human retrovirus by APOBEC3G.
###end article-title 52
###begin article-title 53
###xml 49 84 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 89 123 <span type="species:ncbi:45617">human endogenous retrovirus HERV-K</span>
Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.
###end article-title 53
###begin article-title 54
Complementary function of the two catalytic domains of APOBEC3G.
###end article-title 54
###begin article-title 55
###xml 14 48 <span type="species:ncbi:11908">human T cell leukemia virus type 1</span>
Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid.
###end article-title 55
###begin article-title 56
The betaretrovirus Mason-Pfizer Monkey Virus selectively excludes simian APOBEC3G from virion particles.
###end article-title 56
###begin article-title 57
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human T cell leukemia virus type I is resistant to the antiviral effects of APOBEC3.
###end article-title 57
###begin article-title 58
###xml 28 49 <span type="species:ncbi:11786">murine leukemia virus</span>
Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.
###end article-title 58
###begin article-title 59
APOBEC3G targets specific virus species.
###end article-title 59
###begin article-title 60
Cytidine deamination of retroviral DNA by diverse APOBEC proteins.
###end article-title 60
###begin article-title 61
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 31 37 <span type="species:ncbi:10090">murine</span>
Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms.
###end article-title 61
###begin article-title 62
###xml 43 66 <span type="species:ncbi:11786">murine leukemia viruses</span>
The incorporation of APOBEC3 proteins into murine leukemia viruses.
###end article-title 62
###begin article-title 63
###xml 17 51 <span type="species:ncbi:11908">human T-cell leukemia virus type 1</span>
APOBEC3G targets human T-cell leukemia virus type 1.
###end article-title 63
###begin article-title 64
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.
###end article-title 64
###begin article-title 65
Species specific restriction of Apobec3 mediated hypermutation.
###end article-title 65
###begin article-title 66
###xml 16 22 <span type="species:ncbi:10090">murine</span>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 55 78 <span type="species:ncbi:11786">murine leukemia viruses</span>
Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses.
###end article-title 66
###begin article-title 67
###xml 47 76 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.
###end article-title 67
###begin article-title 68
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1.
###end article-title 68
###begin article-title 69
DNA deamination mediates innate immunity to retroviral infection.
###end article-title 69
###begin article-title 70
###xml 32 37 <span type="species:ncbi:9606">human</span>
Broad antiretroviral defense by human APOBEC3G through lethal editing of nascent reverse transcripts.
###end article-title 70
###begin article-title 71
APOBEC3 proteins and reverse transcription.
###end article-title 71
###begin article-title 72
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).
###end article-title 72
###begin article-title 73
A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action.
###end article-title 73
###begin article-title 74
###xml 25 54 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Further investigation of simian immunodeficiency virus Vif function in human cells.
###end article-title 74
###begin article-title 75
###xml 104 107 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.
###end article-title 75
###begin article-title 76
###xml 0 4 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
MMTV infectious cycle and the contribution of virus-encoded proteins to transformation of mammary tissue.
###end article-title 76
###begin article-title 77
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Interactions between host and viral genomes in mouse leukemia.
###end article-title 77
###begin article-title 78
Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex.
###end article-title 78
###begin article-title 79
###xml 61 67 <span type="species:ncbi:10090">murine</span>
Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus.
###end article-title 79
###begin article-title 80
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians.
###end article-title 80
###begin article-title 81
Host genetic factors that control immune responses to retrovirus infections.
###end article-title 81
###begin article-title 82
###xml 14 20 <span type="species:ncbi:10090">murine</span>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
###xml 84 109 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection.
###end article-title 82
###begin article-title 83
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor.
###end article-title 83
###begin article-title 84
###xml 0 29 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 60 66 <span type="species:ncbi:10090">murine</span>
Moloney murine leukemia virus infection in mice lacking the murine APOBEC3 gene.
###end article-title 84
###begin article-title 85
APOBEC3G genetic variants and their influence on the progression to AIDS.
###end article-title 85
###begin article-title 86
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals.
###end article-title 86
###begin article-title 87
Population stratification of a common APOBEC gene deletion polymorphism.
###end article-title 87
###begin article-title 88
###xml 75 80 <span type="species:ncbi:9606">human</span>
Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H.
###end article-title 88
###begin p 89
The author has declared that no competing interests exist.
###end p 89
###begin p 90
The author received no specific funding for this article.
###end p 90

